StockTipsArenaBeta

BUY Zydus Lifesciences Limited — Prakash Gaba

BUYZydus Lifesciences Limited
Zydus Lifesciences share price target & all analyst calls

byPrakash GabaHorizon: BTST27 Aug 2026, 3:14 pm ISTvia CNBC Awaaz.

Entry₹1,189.2Inferred
Target₹1,200
Total upside +0.91% (call closed)
Stop loss₹1,165-2.03% risk
At expiry₹1,17328 Aug 2026, 3:05 pm
Expired-1.36%
Follow Prakash Gaba for new calls(20% target hit, 382 closed calls)Get alertsWatch ZYDUSLIFE for new buy/sell callsGet alertsSee 3 active BTST picks this session

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

Frozen at close · 28 Aug 2026
5 supporting0 opposing
Supports the BUY call (5)

2 advisors have active swing BUY calls on this stock, all issued in the last 14 days

Advisor consensus · adjacent horizon·27 Aug · today

Zydus Lifesciences Share Price In Focus After Macquarie Maintains Outperform Rating. Here's Why

NewsNdtv-Profit·27 Aug · yesterday

(opens in new tab)

Zydus Lifesciences Shares Tick Higher On USFDA Nod For Ascorbic Aid Injection

NewsNdtv-Profit·21 Aug · 6d ago

(opens in new tab)

Zydus Lifesciences gets USFDA approval for generic Ascorbic Acid Injection

NewsCnbc-Tv18·21 Aug · 1w ago

(opens in new tab)

Zydus Lifesciences Ltd received final approval from the USFDA for Ascorbic Acid Injection, including 180-days CGT exclusivity.

BSE · Company Update·21 Aug · 1w ago

(opens in new tab)
Neutral / worth noting (0)

Nothing found in this tip’s window yet.

Weighs against the BUY call (0)

Nothing found in this tip’s window yet.

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

Other calls on Zydus Lifesciences

All analyst calls on Zydus Lifesciences

More from Prakash Gaba

Every call and its outcome